Reversal of multidrug resistance to cancer chemotherapy

46Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the past few years, the role of membrane‐bound transport genes in human disease has been increasingly recognized and understood. Of these genes, the p170 membrane glycoprotein may function as an outward transport pump for many cancer chemotherapeutic drugs associated with the multidrug resistance phenotype. This article reviews the different classes of the current major modulators of multidrug resistance. Copyright © 1993 American Cancer Society

Cite

CITATION STYLE

APA

Leyland‐Jones, B., Dalton, W., Fisher, G. A., & Sikic, B. I. (1993). Reversal of multidrug resistance to cancer chemotherapy. Cancer, 72(11 S), 3484–3488. https://doi.org/10.1002/1097-0142(19931201)72:11+<3484::AID-CNCR2820721615>3.0.CO;2-L

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free